Survey on Compliance Management in the Life Sciences Industry

Image via Wikipedia

For having participated to a survey for Cegedim, I had the result of it today and want to share it with you .

It is said to be a comprehensive report on the survey results.

You can download it on their website – see the  following link « 2010 European Trends in Aggregate Spend, Transparency and Disclosure » in PDF format.

This is a important signal that companies are awareness to improve compliance and transparency,  that they have no doubt about the fact this is useful/essential for their business and credibility even if the path is not too easy (I remenber reactions a fiew years ago: « Compliance ? what for ? ») and I am delighted to see we go forward to a better approach of business.

Here’s a preview of some of the facts you will find in the report:

	93% of respondents agree that regulatory compliance will be a major challenge in Europe.
	62% of respondents agree that the implementation of transparency guidelines will generate promotional spend decreases.
	53% of respondents anticipate their investment in aggregate spend transparency to grow

Related Articles

• IMS Launches Integrated Regulatory Compliance Solution for Pharmaceutical and Medical Device Companies (eon.businesswire.com)
• Ipswitch Unveils WhatsUp Event Log Management 9.0 (eon.businesswire.com)
• QPharma, Inc. Launches qSpendTM (eon.businesswire.com)

Publicité